Needham Reiterates Buy on Omada Health, Maintains $28 Price Target
Needham analyst Ryan MacDonald reiterates Omada Health (NASDAQ:OMDA) with a Buy and maintains $28 price target.
Share
Why It Matters
A stock expert named Ryan MacDonald still thinks Omada Health is a good company and that its stock is worth around $28. When an expert keeps saying something is good, it means they still see reasons to like it.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.